​

Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewFinancialsChartTranscripts

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 49.64% institutional investors, 32.62% insiders, and 17.74% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 5.57% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma49.64%32.62%17.74%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.31M5.57%$27.60M
Vanguard capital management907.27K3.86%$19.16M
Vanguard group845.50K3.72%$6.38M
Iridian asset management llc/ct651.76K2.99%$5.04M
Geode capital management503.37K2.14%$10.63M
Baldwin brothers llc/ma378.63K1.74%$2.93M
State street369.00K1.57%$7.79M
Occam crest management lp357.15K1.52%$7.54M
Vanguard fiduciary trust148.71K0.63%$3.14M
Vanguard portfolio management145.91K0.62%$3.08M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Occam crest management lp357.15K4.02%$7.54M
Iridian asset management llc/ct651.76K2.04%$5.04M
Baldwin brothers llc/ma378.63K0.21%$2.93M
Austin wealth management20.13K0.09%$405.12K
Knott david m jr6.78K0.08%$143.13K
Pavaki capital management7.50K0.05%$158.40K
Forbes j m & co llp59.00K0.04%$456.07K
Oppenheimer86.29K0.02%$1.82M
Avalon trust14.00K0.02%$295.68K
Nbc securities4.00K0.01%$84.48K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.31M0.00%305.69K
Vanguard group845.50K0.00%146.79K
State street369.00K0.00%120.80K
Fmr112.22K0.00%104.16K
Invesco89.30K0.00%89.30K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
Kalehua capital management---100.00K
Sixth street partners management company---57.13K
Renaissance---42.80K
Stonepine capital management---40.00K

New Positions

HolderShares% AssetsChangeValue
Invesco89.30K0.00%89.30K$1.89M
Citadel advisors78.42K0.00%78.42K$606.23K
Acadian asset management31.44K0.00%31.44K$661.00K
Quadrature capital24.70K0.00%24.70K$521.68K
Squarepoint ops19.09K0.00%19.09K$403.29K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Mai capital management-9.00
Nisa investment advisors-12.00
Point72 (difc)-49.00
Federated hermes-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202689-4.30%11,652,75613.12%492.58%63-4.55%138.33%
Jun 30, 20269347.62%10,304,769127.99%4311.78%6776.32%1122.22%
Mar 31, 202637-27.45%3,045,927-28.14%134.01%16-44.83%5-44.44%
Dec 31, 202538-30.91%3,940,7276.65%175.80%23-8.00%6-60.00%
Sep 30, 20255519.57%3,694,86214.85%177.63%25-24.24%15114.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv650.49K2.53%210.80K
Vanguard Morn Total Stk Mkt Idx Investor650.49K2.06%210.80K
Vanguard MStar Total Stk Mkt Idx Invest650.49K2.02%-
iShares Russell 2000 ETF522.81K1.52%-
Vanguard Institutional Extnd Mkt Idx Tr201.56K0.62%442.00
iShares Russell 2000 Growth ETF194.00K0.56%-735.00
Fidelity Small Cap Index187.29K0.54%-
Russell 2000 Index Non-Lendable Fund113.01K0.44%34.38K
Russell 2000 Equity Index Fund B113.01K0.44%34.38K
Vanguard Russell 2000 ETF121.50K0.38%23.27K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 30, 2026Mosseri Marlio Charles-Buy$916.00K
Jun 30, 2026BENTSUR RON Chairman & CEOBuy$250.00K
Nov 05, 2025BENTSUR RON Chairman & CEOBuy$28.60K
Nov 05, 2025Sanchez Juan-Buy$75.27K
Nov 05, 2025Kaplan Matthew L.-Buy$64.24K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q22-
2026 Q1--
2025 Q46-
2025 Q218-

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 49.64%, followed by 32.62% insiders and 17.74% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 181.71%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Blackrock funding, inc. /de (1.31M shares, 5.57%), Vanguard capital management (907.27K shares, 3.86%), and Vanguard group (845.5K shares, 3.72%). Together, they hold 13.15% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

BlackRock is not among the top 10 institutional shareholders of Nuvectis Pharma.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Occam crest management lp is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 4.02% of its assets in 357.15K Nuvectis Pharma shares, valued at 7.54M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 2.53% of its total shares outstanding invested in 650.49K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools